UK tax break to yield big GSK manufacturing investment

GlaxoSmithKline says it plans to use the UK's upcoming 10-percent "patent box" tax break to scale up current manufacturing and build "a significant new plant." It says it will also develop technology in what may turn out to be the windfall that the UK government is hoping for, with the promise of 1,000 jobs. Article

Suggested Articles

Racing with some COVID-19 vaccine heavyweights, Novavax has brought on a partner to manufacture adjuvant for its in-development shot. 

The FDA recently asked five drug manufacturers to recall the commonly used diabetes med metformin. With COVID-19 raging, is metformin just the start?

The antidepressant Zoloft and its generics are in short supply as the COVID-19 pandemic has caused higher demand and manufacturing interruptions.